Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.
The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.
Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause undue fatigue, palpitations, dyspnea, or anginal pain. These patients remain asymptomatic during daily activities.
Class II: This class includes patients with a slight limitation of physical activity. They are comfortable at rest, but ordinary activities like walking up stairs or carrying groceries cause fatigue, palpitations, dyspnea, or anginal pain.
Class III: Patients in this class have a marked limitation of physical activity. They are comfortable at rest, but less-than-ordinary activities cause significant symptoms. Mild activities such as dressing or light housework can lead to fatigue, shortness of breath, or discomfort, significantly limiting their daily activities.
Class IV: This class comprises patients who are not able to perform any type of physical activity without discomfort. Symptoms of heart failure or anginal syndrome are present even at rest, and any physical activity exacerbates these symptoms. These patients experience severe fatigue, palpitations, or shortness of breath even with minimal exertion and may have chest pain at rest.
Classification Based on Disease Progression and Severity:
Another classification is based on the progression and severity of HF as well as treatment strategies.
Stage A: This stage includes patients at high risk for developing heart failure but do not yet have structural heart disease or symptoms. Risk factors include hypertension, diabetes, obesity, metabolic syndrome, or a family history of cardiomyopathy. Management focuses on lifestyle modification and treatment of underlying conditions to prevent the development of heart failure.
Stage B (Pre-heart failure): Patients in this stage have structural heart disease but have never shown signs or symptoms of heart failure. Examples include patients with previous myocardial infarction, left ventricular hypertrophy, or reduced ejection fraction. Treatment aims to slow disease progression and includes medications like beta-blockers or ACE inhibitors, as well as continued management of risk factors.
Stage C (Symptomatic heart failure): This stage involves patients who have structural heart disease and are experiencing, or have previously experienced, symptoms of heart failure. These symptoms may include dyspnea, fatigue, and a decreased capacity for physical activity. Management focuses on relieving symptoms, improving quality of life, and preventing hospitalizations. It typically involves a combination of medications, lifestyle changes, and possibly device therapy (e.g., implantable cardioverter-defibrillators or cardiac resynchronization therapy).
Stage D (Advanced heart failure): Stage D is defined by advanced heart failure with severe symptoms that are refractory to conventional treatment. Patients in this stage experience significant limitations and discomfort with any physical activity or even at rest. Management includes specialized interventions such as mechanical circulatory support, heart transplantation, or palliative care to improve quality of life.
The common classifications of heart failure include the following:
Firstly, the functional classification of heart failure divides patients into four classes.
Class I involves no limitations or symptoms during ordinary activities, such as walking.
Class II includes slight limitations, with symptoms during ordinary activities.
Class III has marked limitations, with symptoms during less-than-ordinary activities.
Class IV presents severe limitations, with symptoms even at rest.
The next classification is based on disease progression and severity and includes four stages.
Stage A identifies patients at high risk for developing heart failure without structural heart disease or symptoms; management focuses on treating risk factors.
Stage B signifies structural heart disease without symptoms, with treatment including beta-blockers or ACE inhibitors.
Stage C covers patients with structural heart disease with current or past symptoms, managed with medications, lifestyle changes, and possibly devices.
Stage D represents advanced heart failure with severe symptoms refractory to treatment, requiring advanced interventions like mechanical support.
繁體中文
